Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
March 15, 2023 -- Healthcare software firm Sophia Genetics said on Tuesday that it is partnering with Agilent Technologies to offer a comprehensive solution for cancer analysis. Read More
Prenetics acquiring majority stake in ACT Genomics, expanding position in cancer genetics, precision oncology
December 19, 2022 -- Hong Kong-based Prenetics Global, a genomics and diagnostic testing firm, on Friday announced that it is acquiring a majority stake in Taiwan-based precision oncology firm ACT Genomics. Read More
Machine learning used to encode commands for immune cells
December 9, 2022 -- Researchers at University of California San Francisco (UCSF), in collaboration with a team at IBM Research, have developed a virtual molecular library of thousands of “command sentences” for cells, based on combinations of “words” that guide engineered immune cells to seek out and kill cancer cells without pausing. Read More
Salk Institute scientists identify oncogene activation
December 8, 2022 -- Researchers at the Salk Institute have zeroed in on the mechanisms that activate oncogenes, showing that genetic mutation activity depends on the distance between a particular gene and the sequences that regulate the gene. Read More
Shenandoah expands cytokine, growth factors portfolio for cell and gene therapies
December 7, 2022 -- Shenandoah Biotechnology, a Fujifilm Irvine Scientific company, has announced the expansion of its CTGrade portfolio of cytokine and growth factors for cell and gene therapies that are manufactured following current good manufacturing practices. Read More
New method helps scientists identify efficient, tailored AI algorithms
December 6, 2022 -- Researchers from Cold Spring Harbor Laboratory have developed a new method designed to assist scientists in choosing artificial intelligence (AI) algorithms that best fit their needs. Their findings may help researchers in identifying more efficient AI programs to analyze the human genome. Read More
Transcriptomics help visualize diffuse midline glioma
December 6, 2022 -- A Dana-Farber-led team used spatial single-cell transcriptomics to visualize diffuse midline glioma cancer cell structure across different age groups and locations. Their study, published December 5 in the journal Nature Genetics, provides insights that may facilitate new treatment approaches for this rare cancer. Read More
Researchers pinpoint gene leading to childhood glaucoma
December 5, 2022 -- A genetic mutation in the thrombospondin-1 gene leads to the development of severe childhood glaucoma and the discovery may improve disease screening and personalize treatments, a team of scientists has found. Read More
CIRM awards $8M for gene therapy research on rare, incurable diseases
December 2, 2022 -- The California Institute for Regenerative Medicine (CIRM) has awarded $8 million in grants for two research teams investigating gene therapy for rare and incurable diseases. Read More
CRISPR-based tool cuts and pastes genes where needed
November 28, 2022 -- Massachusetts Institute of Technology researchers have designed a new CRISPR-based tool that can snip out faulty DNA sequences and safely replace them with new ones at desired cell sites. Read More
Conferences
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
